Cargando…

Percutaneous Radiofrequency Ablation Combined With Chemotherapy Versus Chemotherapy Only for Ovarian Cancer Liver Metastasis

PURPOSE: To compare the feasibility and efficacy of radiofrequency ablation (RFA) combined with chemotherapy and chemotherapy alone in patients with ovarian cancer liver metastasis (OCLM). METHODS: In this retrospective study, a total of 60 patients diagnosed with OCLM between May 2015 to February 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chun-Xue, Chen, Miao-Ling, Zhang, Hao, Han, Jian-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761983/ https://www.ncbi.nlm.nih.gov/pubmed/35047404 http://dx.doi.org/10.3389/fonc.2021.793024

Ejemplares similares

Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study
por: Chen, Yizhen, et al.
Publicado: (2021)

Ultrasound-guided secondary radiofrequency ablation combined with chemotherapy in gastric cancer with recurrent liver metastasis
por: Fan, Xiaoxiang, et al.
Publicado: (2020)

Systemic chemotherapy combined with radiofrequency ablation for colorectal cancer with liver metastasis: a retrospective cohort study
por: Tran, Thang, et al.
Publicado: (2023)

Percutaneous Microwave Ablation Versus Open Surgical Resection for Colorectal Cancer Liver Metastasis
por: Zhao, Qinxian, et al.
Publicado: (2021)

Comparison of Percutaneous Radiofrequency Ablation for Subcapsular and Non-Subcapsular Colorectal Cancer Liver Metastases
por: Fan, Hongjie, et al.
Publicado: (2021)

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Percutaneous Radiofrequency Ablation Is an Effective Method for Local Control of Liver Metastases From Lung Cancer
por: Zhang, Zhong-Yi, et al.
Publicado: (2022)

Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer
por: Tang, Kezhong, et al.
Publicado: (2020)

Comparison of the Efficacy of D2 Gastrectomy Plus Liver Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone in the Treatment of Advanced Gastric Cancer With Unresectable Synchronous Liver Metastases: A Multicenter Randomized Controlled Trial Protocol
por: Wang, Weidong, et al.
Publicado: (2022)

Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis
por: Thai Doan, Ky, et al.
Publicado: (2020)

Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?
por: Govaert, Klaas M., et al.
Publicado: (2012)

Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Can Radiofrequency Ablation Replace Liver Resection for Solitary Colorectal Liver Metastasis? A Systemic Review and Meta-Analysis
por: Hao, Wu, et al.
Publicado: (2020)

Clinical Efficacy of Interventional Chemotherapy Embolization Combined with Monopolar Radiofrequency Ablation on Patients with Liver Cancer
por: Tian, Zhenhua, et al.
Publicado: (2022)

Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy
por: Möhring, Christian, et al.
Publicado: (2023)

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
por: Chen, Rui, et al.
Publicado: (2023)

Retracted: Clinical Efficacy of Interventional Chemotherapy Embolization Combined with Monopolar Radiofrequency Ablation on Patients with Liver Cancer
por: Oncology, Journal of
Publicado: (2023)

Risk factors for pulmonary cement embolism after percutaneous vertebroplasty and radiofrequency ablation for spinal metastases
por: Wang, Luqiang, et al.
Publicado: (2023)

Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study
por: Ou, Shuangyan, et al.
Publicado: (2018)

Efficacy and adverse reaction management of oncolytic viral intervention combined with chemotherapy in patients with liver metastasis of gastrointestinal malignancy
por: Zhang, Jie, et al.
Publicado: (2023)

The Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Ovarian Cancer
por: Li, Zhihui, et al.
Publicado: (2018)

Editorial: Radiofrequency ablation in liver cancers: Investigations of efficacy as monotherapy and polytherapy
por: Rompianesi, Gianluca
Publicado: (2022)

Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
por: Curley, Steven A.
Publicado: (2007)

Percutaneous Radiofrequency Ablation for Liver Tumors: Technical Tips
por: Sato, Yozo, et al.
Publicado: (2020)

Liver resection, radiofrequency ablation, and radiofrequency ablation combined with transcatheter arterial chemoembolization for very-early- and early-stage hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis for comparison of efficacy
por: Zhang, Yunlong, et al.
Publicado: (2022)

Recent Updates on Local Ablative Therapy Combined with Chemotherapy for Extrahepatic Cholangiocarcinoma: Photodynamic Therapy and Radiofrequency Ablation
por: Inoue, Tadahisa, et al.
Publicado: (2023)

A systematic review and meta-analysis comparing tumor progression and complications between radiofrequency ablation and thyroidectomy for papillary thyroid carcinoma
por: Sun, Yuan-dong, et al.
Publicado: (2022)

Therapeutic Efficacy of Percutaneous Radiofrequency Ablation versus Microwave Ablation for Hepatocellular Carcinoma
por: Zhang, Lei, et al.
Publicado: (2013)

Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation
por: Zhang, Lei, et al.
Publicado: (2023)

Efficacy and survival of anti-PD-1 antibody in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy as first-line treatment of HER2-positive metastasis gastric adenocarcinoma: a retrospective study
por: Deng, Ting, et al.
Publicado: (2023)

Percutaneous radiofrequency ablation on a Xp11.2 Translocation Renal Cell Carcinoma: A case report
por: Kanas, Alexandre Fligelman, et al.
Publicado: (2020)

Retrograde Transpubic Approach for Percutaneous Radiofrequency Ablation and Cementoplasty of Acetabular Metastasis
por: Bauones, Salem, et al.
Publicado: (2015)

Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study
por: Ding, Xiaoyan, et al.
Publicado: (2020)

Synchronous Microwave Ablation Combined With Cisplatin Intratumoral Chemotherapy for Large Non-Small Cell Lung Cancer
por: Huang, Guanghui, et al.
Publicado: (2022)

Ten-Year Outcomes of Percutaneous Radiofrequency Ablation for Colorectal Cancer Liver Metastases in Perivascular vs. Non-Perivascular Locations: A Propensity-Score Matched Study
por: Jiang, Binbin, et al.
Publicado: (2020)

Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer
por: Feldbrügge, Linda, et al.
Publicado: (2021)

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
por: Walma, M. S., et al.
Publicado: (2021)

EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study
por: Kongkam, Pradermchai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mbffi385mpkc9bg9roh0bf6jlv